Abnormal methylation of promoter sites of two key tumor suppressor genes in lung cancer may be detected in sputum by sensitive techniques long before clinical manifestation of the disease. This hypermethylation that silences the function of these genes may be a very early abnormality in the development of lung cancer. This non-invasive procedure can be implemented in screening lung cancer in the general public.
Go to Previous Page
Go to Next Page